Wertpapiere

Name Mnemo Börse Durchschn. Volumen Kurs Typ
LEVI STRAUSS & CO. A2PFHR

Nyse +9 Andere

1 426 869 23,53 USD Aktie Levi Strauss & Co. Aktie
LEVI STRAUSS & CO. A2PFHR

Deutsche Boerse AG

- 21,82 EUR Aktie Levi Strauss & Co.
LEVI STRAUSS & CO. A2PFHR

Börse Stuttgart

- 21,83 EUR Aktie Levi Strauss & Co.
LEVI STRAUSS & CO. LEVI

Wiener Boerse

- 21,98 EUR Aktie Levi Strauss & Co.
LEVI STRAUSS & CO. A2PFHR

London S.E.

306 16,62 EUR Aktie Levi Strauss & Co.
LEVI STRAUSS & CO. A2PFHR

Mexican S.E.

428 406 MXN Aktie Levi Strauss & Co.
LEVI STRAUSS & CO. A2PFHR

Frankfurt am Main

188 18,7 EUR Aktie Levi Strauss & Co.
LEVI STRAUSS & CO. A2PFHR

BOERSE MUENCHEN

133 21,89 EUR Aktie Levi Strauss & Co.
LEVI STRAUSS & CO. A2PFHR

Borsa Italiana

- 21,91 EUR Aktie Levi Strauss & Co.
LEVI STRAUSS & CO. A2PFHR

Berne S.E.

- - CHF Aktie Levi Strauss & Co.
RAMI LEVI CHAIN STORES HASHIKMA MARKETING 2006 LTD A0YAH7

TEL AVIV STOCK EXCHANGE +1 Andere

30 976 20.070 ILa Aktie Rami Levi Chain Stores Hashikma Marketing 2006 Ltd Aktie
RAMI LEVI CHAIN STORES HASHIKMA MARKETING 2006 LTD A0YAH7

OTC Markets

135 67,95 USD Aktie Rami Levi Chain Stores Hashikma Marketing 2006 Ltd
LEVI STRAUSS & CO. A3KLMX

BOERSE MUENCHEN

- 87,11 % Anleihe Levi Strauss & Co. Anleihe
LEVI STRAUSS & CO. A19HE9

Deutsche Boerse AG

- 97,84 % Anleihe Levi Strauss & Co. Anleihe
LEVI STRAUSS & CO. A19D0A

Deutsche Boerse AG

- 97,6 % Anleihe Levi Strauss & Co. Anleihe
LEVI STRAUSS & CO. A19D0A

BOERSE MUENCHEN

- 98,22 % Anleihe Levi Strauss & Co. Anleihe
LEVI STRAUSS & CO. A3KLMX

Börse Stuttgart

- 86,47 % Anleihe Levi Strauss & Co. Anleihe
LEVI STRAUSS & CO. A19HE9

Börse Stuttgart

- 97 % Anleihe Levi Strauss & Co. Anleihe
LEVI STRAUSS & CO. A19HE9

BOERSE MUENCHEN

- 98,29 % Anleihe Levi Strauss & Co. Anleihe
LEVI STRAUSS & CO. A3KLMX

Deutsche Boerse AG

- 87,14 % Anleihe Levi Strauss & Co. Anleihe

Nachrichten (41)

Roche-Krebsmittel Inavolisib wird von FDA beschleunigt überprüft AW
Roche-Studie zu Abnehm-Spritze zeigt frühe Erfolge DJ
Roche erzielt mit Krebsmittel Columvi Forschungserfolg bei Blutkrebs AW
Roche legt neue Langfrist-Daten zu Brustkrebsmittel Kadcyla vor AW
Roche verbessert mit Inavolisib-Kombination Überleben von Krebspatienten DP
Roche verbessert mit Inavolisib-Kombination Überleben bei Krebspatienten AW
Roche legt positive Daten zu MS-Medikament Fenebrutinib vor AW
Roche erzielt mit Augenmittel Vabysmo weiteren Behandlungserfolg AW
Roche mit ermutigenden Studienergebnissen für Bluterkrankungs-Medikament AW
Roche legt nach Corona-Boom eine Wachstumspause ein AW
Morning Briefing - Markt Schweiz AW
Roche ernennt Teresa Graham zur Pharmachefin AW
[Ad hoc-Mitteilung gemäss Art. 53 KR] Veränderungen in der Konzernleitung von Roche GL
Roche Holding AG gibt die Ernennung von Führungskräften bekannt CI
Roche-Augenmittel Vabysmo senkt Behandlungszeiträume bei nAMD AW
Roche bekommt von FDA für neuartige Blutkrebs-Therapie beschleunigte Überprüfung AW
Roche erhält EU-Zulassung für Tecentriq als adjuvante Krebstherapie DJ
Roche erhält Genehmigung der EU-Kommission für Behandlung mit Polivy AW
Roche will an Krebskongress Asco Einblick in Forschungspipeline geben AW
Roche erreicht Ziele in Phase-III mit Tiragolumab bei best. Lungenkrebs nicht AW
Roche kündigt für neurologischen Fachkongress AAN Vielzahl an Daten an AW
Roche erhält FDA-Status 'Priority Review' für ergänzenden Antrag zu SMA-Mittel AW
Wdh: Roche erhält US-Zulassung für Augenimplantat Susvimo AW
Roche erreicht in Phase-III-Studie mit Polivy-Kombination gesteckte Ziele AW
Roche nimmt erste Hürde mit US-Zulassungsantrag für Augenmittel Faricimab AW
Roches Covid-19-Medikament Ronapreve erhält Zulassung in Japan DJ
Roche kündigt neue Daten zu Hämophilie-Therapien an AW
Roche plant Stellenabbau in Entwicklungssparte AW
Roche-Tochter Genentech erhält FDA-Notfallzulassung für Actemra AW
Roche präsentiert Fortschritte mit Immuntherapien bei Non-Hodgkin-Lymphomen AW
Roche-Studie zeigt Erfolge von Casirivimab, Imdevimab bei Corona DJ
Roche erreicht in Tecentriq-Studie IMpower010 gesteckte Ziele bei Lungenkrebs AW
Roche zieht in den USA Tecentriq für bestimmten Blasenkrebs zurück AW
Roche präsentiert aktualisierte Daten zu Tecentriq-Kombination bei Leberkrebs AW
Roche erhält US-Zulassung für Erstlinien-Monotherapie mit Tecentriq zu NSCLC AW
Roche erhält positive CHMP-Empfehlung für Venclyxto/Gazyvaro-Kombination AW
Roche erleidet Rücksetzer bei Blasenkrebs DP
Roche erleidet Rücksetzer bei Blasenkrebs - Schweiz-Zulassung für Kadcyla AW
Roche erhält EU-Zulassung für Polivy zur Behandlung von Lymphdrüsenkrebs AW
Roche-Therapie verbessert Überlebenschancen von Leberkrebs-Patienten AW
Roche ernennt neuen Entwicklungschef AW

Unternehmen (5)

LEVI STRAUSS & CO. 9 366 Mio $
Logo Levi Strauss & Co.

Levi Strauss & Co. ist ein Bekleidungsunternehmen. Das Unternehmen entwirft und vertreibt Jeans, Freizeitkleidung und dazugehörige Accessoires für Männer, Frauen und Kinder unter den Marken Levi's, Signatureby Levi Strauss & Co., Denizen, Dockers ...

RAMI LEVI CHAIN STORES HASHIKMA MARKETING 2006 LTD 742 Mio $
Logo Rami Levi Chain Stores Hashikma Marketing 2006 Ltd

Rami Levi Chain Stores Hashikma Marketing 2006 Ltd. ist eine in Israel ansässige Discounterkette, die 14 Filialen in Jerusalem sowie in den umliegenden Gebieten von Shilat (Modiin), Mishor Adomim, Mevaseret Zion und Shaar Benyamin betreibt. Das Unternehme ...

CREDO BRANDS MARKETING LIMITED 125 Mio $
Logo Credo Brands Marketing Limited

Credo Brands Marketing Ltd ist ein in Indien ansässiges Unternehmen, das unter dem Markennamen MUFTI modische Freizeitkleidung und Accessoires verkauft. Das Unternehmen ist im Geschäftssegment Freizeitkleidung und -bekleidung für Männer tätig. Zu seinen P ...

NICHOLS PLC 467 Mio $
Logo Nichols plc

Nichols plc ist ein internationales Unternehmen für alkoholfreie Getränke. Das Unternehmen liefert Erfrischungsgetränke an den Einzelhandel, den Großhandel, die Gastronomie, die Lizenz- und Freizeitindustrie. Nichols ist in über 73 Ländern vertreten und v ...

WA KAOLIN LIMITED 14 Mio $
Logo WA Kaolin Limited

WA Kaolin Limited ist ein in Australien ansässiges Unternehmen, das Mineralien exploriert, abbaut und verarbeitet. Die Hauptaktivitäten des Unternehmens sind die Exploration und Erschließung einer abgeleiteten Mineralressource von hochwertigem, kaolinisie ...


Insiders

Foto Levi Garraway
Levi Garraway

Levi A.
Garraway
is the founder of Foundation Medicine, Inc. (founded in 2009) and Tango Therapeutics Sub, Inc. (founded in 2017).
He is currently the Director, Chief Medical Officer & Executive VP at Genentech, Inc. since 2019 and the Chief Medical Officer & Head-Product Development at Roche Holding AG.
Dr. Garraway's former positions include being the Director at the American Association for Cancer Research, Senior VP-Global Development & Medical Affairs at Eli Lilly & Co. from 2017 to 2019, and Assistant Professor at Dana-Farber Cancer Institute, Inc. from 2007 to 2011.


Foto Yaron Levi
Yaron Levi

Yaron R.
Levi
is currently the Chief Information Security Officer at Dolby Laboratories, Inc. He is also an Advisor at YL Ventures LLC, Safebreach, Inc., Capri Ventures LLC, Cyberstarts VC, and Silicon Valley CISO Investments.
In addition, he is an Advisor at Glilot Capital Investments GP Ltd.
and currently holds advisory positions at NTT Security AppSec Solutions, Inc., Optiv, Inc., and IntSights Cyber Intelligence Ltd.
Previously, he worked as the Director of Information Security at Cerner Corp., Director at TTI Telecom International Ltd., Principal & Information Security Business Partner at Intuit, Inc., and as a Member of the Board of Advisors at NTT Security AppSec Solutions, Inc., Optiv, Inc., and IntSights Cyber Intelligence Ltd.


Foto Avi Levi
Avi Levi

Avi Levi is currently the Chief Executive Officer at Israel Discount Bank Ltd.
He previously served as the Chairman at IDB (Swiss) Bank Ltd.
and Discount Trust Ltd.
Mr. Levi received his undergraduate degree from Tel-Aviv University in 1991 and his MBA from Bar-Ilan University in 2005.


Foto Pierre Levi
Pierre Levi

Pierre Levi is currently an Independent Director at Global Bioenergies SA, a Director at B Cell Design SAS, a Director at Rispa, and a Co-Manager at Metman Capital SARL.
Previously, he held positions such as Chairman & Chief Executive Officer at Forvia SE, Chief Executive Officer at Compagnie des Salins du Midi et des Salines de l'Est SASU, Deputy Chairman at Solvay France SA, and Deputy Chairman at Rhone-Poulenc SA. He also served as a Director at Ayming SAS, Kowee SA, and Vegetal SAS.
Mr. Levi received his undergraduate degree from École Nationale Supérieure des Mines de Paris and his MBA from The Wharton School of the University of Pennsylvania.




Foto David A. Garraway
David A. Garraway

David A.
Garraway
currently works as a Director at Vroom Automotive Finance Corp.



Foto Alvin R. Garraway
Alvin R. Garraway

Alvin R.
Garraway
is a Director of Valley Bancorp (Nevada) and a Member of the Nevada Society of CPAs and The American Institute of Certified Public Accountants.
Prior to joining Valley Bancorp (Nevada) in April 19, 2006, he was President and Controller of Oasis Residential, Inc. and an Audit Partner of Horwath Velez & Co. PSC.
He is a Certified Public Accountant.


Foto Richard Garraway
Richard Garraway

Richard Garraway is currently a Director at PBB Devices Ltd.
and a Director & Director-Intellectual Property at Ascension Healthcare Plc.
He was previously a Director at Novacta Biosystems Ltd., an Investment Banker at J.P.
Morgan & Co. Ltd., a Principal at Celtic Pharma Development UK Plc, and the Head-Business Development at Bedford Royalties Ltd.
Garraway holds an MBA and a doctorate from London Business School.



Foto Kendall Garraway
Kendall Garraway

Kendall Garraway currently works at Cotton, Inc., as Director.











Foto John G. Levi
John G. Levi

John G.
Levi
is the founder of AMP Community.
He currently holds the position of Chairman at Legal Services Corp.
and Director at Chicago Child Care Society.


Foto Jeffrey Levi
Jeffrey Levi

Jeffrey Levi is currently the Director at The Trust for America's Health.
He has an undergraduate degree from Oberlin College, a graduate degree from Cornell University, and a doctorate from George Washington University.


Foto Uzi Levi
Uzi Levi

Uzi Levi worked as an Independent Director at Bank of Jerusalem Ltd.
from 2019 to 2020.
He also worked as an Executive Vice President-International Operations at Property & Building Corp.
Ltd.




Foto Mordechai Levi
Mordechai Levi

Mordechai Levi worked as a Vice President-Sales at Shaniv Paper Industry Ltd.



Foto Danny F. Levi
Danny F. Levi

Danny F.
Levi
is the founder of GetAFive, Inc. Prior to founding GetAFive, he worked at Yale University from 2004 to 2008.
He received his undergraduate degree from Yale University in 2008.






Foto Marco Levi
Marco Levi

Marco Levi is currently the Chief Executive Officer & Director at Ferroglobe PLC since 2020.
He is also the Chief Executive Officer at Thermission AG since 2019.
Additionally, he holds the position of Director at Ferroglobe Finance Co. PLC since 2021, Director at Euroalliages Aisbl since 2020, and Independent Director at Mativ Holdings, Inc. since 2017.
In his former positions, Dr. Levi served as the President & Chief Executive Officer at Ahlstrom Oyj from 2014 to 2016.
He was also the Director-Global Business Unit at The Dow Chemical Co. from 2006 to 2009.
Furthermore, he held the role of Independent Director at Schweitzer-Mauduit International, Inc. Dr. Levi's education includes an undergraduate degree from the University of Milan in 1984 and a doctorate degree from the same institution.



Foto Levi Spry
Levi Spry

Mr. Levi Spry is a Mining Analyst at UBS Securities Australia Ltd.
Mr. Spry was previously employed as a Senior Research Analyst by JCP Investment Partners Ltd., an Analyst by GMP Securities Australia Pty Ltd., a Research Analyst by Deutsche Bank AG (Australia), a Research Analyst by JPMorgan Securities Australia Ltd., and a Research Analyst by Patersons Securities Ltd.






Foto Galit Levi
Galit Levi

Galit Levi served as an External Director at E.S.
Australia Israel Holdings Ltd.
before pursuing an undergraduate degree at The Hebrew University of Jerusalem.


Foto Levi Kennedy
Levi Kennedy

Levi Kennedy was the founder of Signal Innovations Group, Inc. founded in 2004 where he held the title of Treasurer.
Currently, he holds the title of Senior Member at The Institute of Electrical & Electronics Engineers, Inc. and is a Member at Eta Kappa Nu.
Previously, he held the title of Principal at Raytheon Missile Systems Co. Mr. Kennedy has an undergraduate degree from Brigham Young University and a graduate degree from North Carolina State University.



Foto Levi Ravina
Levi Ravina

Mr. Levi Ravina is Controller at RAPAC Communication & Infrastructure Ltd.







Foto Stuart D. Levi
Stuart D. Levi

Stuart D.
Levi
is associated with Skadden, Arps, Slate, Meagher & Flom LLP since 2004 as a Partner.
















Foto Esther Levi
Esther Levi

Esther Levi is currently an Independent External Director at Nissan Medical Industries Ltd., a Director at Akum Ltd., an Independent External Director at Ten - Petroleum Co. Ltd., and an Independent Director at Automatic Bank Services Ltd.
She has an undergraduate degree and an MBA from Tel-Aviv University.



Foto Levi Kushnir
Levi Kushnir

Levi Kushnir is currently the Director at Cleveland Diagnostics, Inc. He was formerly the Chairman at Nechushtan Investment Co. Ltd.



Foto Hila Levi
Hila Levi

Hila Levi worked as an Accountant at I.E.S Holdings Ltd.
from 2018 to 2019 and also worked as an Accountant at Ratio Energies LP.
Levi received an undergraduate degree from The College of Management Academic Studies.


Foto Ziv Levi
Ziv Levi

Ziv Levi is the founder and currently serves as the Chief Executive Officer at Arilou Information Security Technologies Ltd, a company he founded in 2010.
He previously worked as the General Counsel & Senior Vice President at Verint Systems, Inc. and as the Chief Legal Officer at Cognyte Software Ltd.



Foto Levi Malik
Levi Malik

Levi Malik is a Principal on the private equity team.
Levi joined Viking in 2021 as a summer intern and rejoined full time in 2022.
Prior to joining Viking, Levi was an Executive Director at Pharmaceutical Product Development, a Private Equity Associate at Hellman and Friedman, and an Investment Banking Analyst at Morgan Stanley.
Levi received an MBA from the Stanford Graduate School of Business and a B.A.
in economics, summa cum laude, from Princeton University.



Foto Mary Levi
Mary Levi

Mary Levi currently works as a Director for the National Education Association.




Foto Amir Levi
Amir Levi

Amir Levi is currently the Managing Partner & Chief Executive Officer at Sphera Funds Management Ltd., the Chief Executive Officer at IBC Israel Broadband Co. (2013) Ltd., and the Director at Social Finance Israel.
He was previously a Director at Ayalon Insurance Co. Ltd.
Mr. Levi received his undergraduate and graduate degrees from The Hebrew University of Jerusalem.


Foto Benedetto Levi
Benedetto Levi

Benedetto Levi founded Extraverso in 2013.
Mr. Levi also currently works at Iliad Italia SpA, as Chief Executive Officer from 2018, Iliad Italia Holding SpA, as Chief Executive Officer, and Unieuro SpA, as Director.
Mr. Levi received his graduate degree from ESCP Europe Campus Paris and undergraduate degree from Politecnico di Torino.






Foto Levi Kobi
Levi Kobi

Levi Kobi currently works as the Chief Executive Officer at Dori TLV Ltd.




Foto Tzedi Levi
Tzedi Levi

Tzedi Levi currently works as a Plant Manager at A.M.S.
Electronics Ltd.





Foto David B. Levi
David B. Levi

Mr. David B.
Levi
is on the Board of Directors at Nutroganics, Inc. Mr. Levi was previously employed as Chairman by Voxware, Inc. He also served on the board at Tvia, Inc. He received his MBA from Harvard University.


Foto Yossef Levi
Yossef Levi

Yossef Levi is currently the Chief Executive Officer & Director at Todos Technologies Ltd., Director at NRGene Technologies Ltd., and Director at Virucure Ltd.
He completed his undergraduate degree from Hadassah College Jerusalem.


Foto Levi Hong Kaye Lee
Levi Hong Kaye Lee

Dr. Levi H.
Lee, MD, is Independent Director at Immtech Pharmaceuticals, Inc. He is on the Board of Directors at Immtech Pharmaceuticals, Inc. and Immtech Hong Kong Ltd.
He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from The University of California, San Francisco.








Foto Levi Roethler
Levi Roethler

Levi Roethler worked as a Junior Economist at Convex Capital Management LLC from 2016 to 2018.
He graduated from the University of Pittsburgh with a graduate degree in 2016 and from the University of Northern Iowa with an undergraduate degree.


Foto Levi Jacobson
Levi Jacobson

Levi Jacobson is currently the Chief Executive Officer, COO, CFO & Secretary at Hemp Naturals, Inc. He is also the President, CEO, CFO, Secretary & Treasurer at C2 Blockchain, Inc., the Director at American Estate Management Co., and the President, Secretary, Treasurer & Director at China Xuefeng Environmental Engineering, Inc. Previously, he worked as the Director, Manager-Sales & Management at Blue Car Enterprise Corp.
in 2015 and as the President, CFO, COO & Secretary at Elektros, Inc. from 2020 to 2021.
Mr. Jacobson completed his undergraduate degree at Touro College in 2014.

Keine Ergebnisse zu dieser Suche

-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT